Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2014
09/12/2014WO2014135439A1 Novel halogen-substituted compounds
09/12/2014WO2014135437A1 Novel halogen-substituted compounds
09/12/2014WO2014135422A1 Antiviral compounds
09/12/2014WO2014135414A1 Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
09/12/2014WO2014134774A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/12/2014WO2014134772A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/11/2014US20140256780 Pyrazole derivatives as modulators of hepatocyte growth factor (scatter factor) activity
09/11/2014US20140256722 Benzoimidazoles as prolyl hydroxylase inhibitors
09/11/2014US20140256708 1,3 substituted azetidine pde10 inhibitors
09/11/2014US20140256707 Heteroaryl Sodium Channel Inhibitors
09/11/2014US20140256703 Aminopyrimidines useful as inhibitors of protein kinases
09/11/2014US20140256701 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/11/2014US20140256684 Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
09/11/2014US20140255428 Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor
09/11/2014US20140255386 Microrna modulators and method for identifying and using the same
09/11/2014US20140255306 Triazine based radiopharmaceuticals and radioimaging agents
09/10/2014EP2774917A1 Pharmaceutical composition for treating diabetes
09/10/2014EP2773642A1 Pak inhibitors for the treatment of cell proliferative disorders
09/10/2014EP2773635A1 Compounds and compositions for modulating egfr activity
09/10/2014EP2773624A1 Novel process for the preparation of acylguanidines and acylthioureas
09/10/2014EP2773622A1 Pesticidal compounds
09/09/2014US8829200 Benzimidazole inhibitors of leukotriene production
09/09/2014US8829199 Aminopyrazole derivative
09/09/2014US8829195 Compounds and compositions for inhibiting the activity of ABL1, ABL2 and BCR-ABL1
09/09/2014US8829041 Cyclopropyl amine derivatives
09/09/2014US8829039 Dihydroindolinone derivatives
09/09/2014US8829036 Heterocyclic aspartyl protease inhibitors
09/09/2014US8829034 Compounds which modulate the CB2 receptor
09/09/2014US8828993 Psychotropic agents having glutamate NMDA activity
09/09/2014US8828991 Azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
09/09/2014US8828644 Compound, photosensitive composition comprising the same and photosensitive material
09/09/2014US8828558 Monoamine compound, charge transport material, composition for charge transport film, organic electroluminescent element, organic EL display, and organic EL lighting
09/09/2014CA2695711C Process for synthesizing compounds useful for treating hepatitis c
09/04/2014WO2014134391A1 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
09/04/2014WO2014134388A1 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
09/04/2014WO2014134313A1 Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereof
09/04/2014WO2014134306A1 Heterocyclic inhibitors of the sodium channel
09/04/2014WO2014132267A1 1-substituted, 4-(substituted phenoxymethyl)-1,2,3-triazole compounds with antifungal properties and methods for preparation thereof
09/04/2014WO2014131315A1 Bridged ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
09/04/2014WO2013134085A8 Inhibitors of beta-secretase
09/04/2014WO2013132352A8 Covalent functionalization of carbon nanotubes grown on a surface
09/04/2014US20140249320 Process for Preparing 5-biphenyl-4-amino-2-methyl Pentanoic Acid
09/04/2014US20140249319 Chemical crosslinkers and compositions thereof
09/04/2014US20140249169 1-pyrazolyl-3- (4- ((2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1- yl) ureas as p38 map kinase inhibitors
09/04/2014US20140249151 Bicyclic heterocyclic compound
09/04/2014US20140249139 Quinazoline Derivatives
09/04/2014US20140249137 Pyrimidine compounds as tuberculosis inhibitors
09/04/2014US20140249135 Pim kinase inhibitors and methods of their use
09/04/2014US20140249134 Triazolyl pde10 inhibitors
09/04/2014US20140249129 Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity
09/04/2014US20140249128 Triazine carboxamides as sodium channel blockers
09/04/2014US20140249025 1,3-diaryl-substituted heterocyclic pesticides
09/04/2014US20140248378 Pyrimidinone compounds and their use
09/03/2014EP2772491A1 Crystals of androgen receptor antagonist compound
09/03/2014EP2772483A1 4-aminocarbazole compound and use of same
09/03/2014EP2771341A1 Novel compositions and methods for treating cancer
09/03/2014EP2771333A1 Application of reduced dyes in imaging
09/03/2014EP2771327A1 Novel pyrazine derivatives
09/03/2014EP2771325A1 Pyridazine derivatives useful in therapy
09/03/2014EP2771319A1 Amino acid derivatives functionalized on the n- terminal capable of forming drug incapsulating microspheres
09/03/2014EP2771069A2 Inhibiting g protein coupled receptor 6 kinase polypeptides
09/02/2014US8822700 Hepatitis C virus inhibitors
09/02/2014US8822690 High transmissional yellow dye for LCD and synthetic method thereof
09/02/2014US8822685 2,4-pyrimidinediamine compounds and their uses
09/02/2014US8822681 Azaindoles useful as inhibitors of janus kinases
09/02/2014US8822522 Dual-acting pyrazole antihypertensive agents
09/02/2014US8822520 Substituted bicyclic HCV inhibitors
09/02/2014US8822513 Compounds for treatment of cancer
09/02/2014US8822476 Piperidine and piperazine derivatives as autotaxin inhibitors
09/02/2014US8822464 N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
09/02/2014US8822459 Compound containing basic group and use thereof
09/02/2014US8822453 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
09/02/2014US8822451 Modulators of ATP-binding cassette transporters
09/02/2014US8822449 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
09/02/2014US8822447 Indazole compounds useful as ketohexokinase inhibitors
09/02/2014US8822430 Antiviral compounds
09/02/2014US8822043 Organic compound and organic light-emitting device
09/02/2014CA2651128C Benzimidazole modulators of vr1
08/2014
08/28/2014WO2014130927A1 Pyrazole azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
08/28/2014WO2014130565A1 Substituted diaryl azetidine derivatives as sphingosine receptor modulators
08/28/2014WO2014130241A1 Fungicidal pyrazoles
08/28/2014WO2014129668A1 Production method of pyridazinone compounds
08/28/2014WO2014128622A1 Quinazolines as kinase inhibitors
08/28/2014WO2014128612A1 Quinazolin-4-one derivatives
08/28/2014WO2014093230A3 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
08/28/2014WO2014083582A3 Novel process for the preparation of (1s,3ar,6as)-2-[(2s)-2-({(2s)-2-cyclohexyl-2-[(pyrazin-2-ylcarbonyl)amino]acetyl}amino)-3,3-dimethylbutanoyl]-n-[(3s)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c] pyrrole-1-carboxamide and its intermediates
08/28/2014WO2013134288A9 Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
08/28/2014US20140243519 Methods and intermediates for preparing macrolactams
08/28/2014US20140243309 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors
08/28/2014US20140243308 Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
08/28/2014US20140243307 Pyrazole azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
08/28/2014US20140243305 Azetidinyl diamides as monoacylglycerol lipase inhibitors
08/28/2014US20140242099 Compounds for inflammation and immune-related uses
08/27/2014EP2770036A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
08/27/2014EP2769978A1 saxagliptin derivatives
08/27/2014EP2769977A1 Heterocyclic Compound and Organic Light-Emitting Diode including the same
08/27/2014EP2768825A2 Processes for the preparation of novel benzimidazole derivatives
08/27/2014EP2768824A2 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
08/27/2014EP2768813A1 Quinazoline derivatives as pi3k modulators
08/27/2014EP2768812A1 Acid addition salts of bosentan
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 626